While both the United States and Europe strive to provide quality cancer care, their systems differ significantly. The US often emphasizes cutting-edge treatments, sometimes leading to higher costs. In contrast, European systems tend to prioritize proactive care and accessibility, focusing on early screening. This can result in different patient ex